All companies
Visit website
MicroMGx Inc
OperatingMicroMGx, Inc.
Industrial · Founded 2015
Make it easier than ever to learn from nature to create chemical products for agriculture, pharmaceuticals, and more
Post-money valuation ⓘ
$11.1M
As of Apr 2023 · from MicroMGx Inc Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$124,508
Across 1 round since 2022
Latest share price
$2.37
MicroMGx Inc Common Stock 1 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$537K
−$270K
2020
$524K
−$134K
2021
$74K
−$96K
2023
$400K
$81K
2024
$38K
−$194K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2023
FY2024
FY2025
Income statement
Revenue
$537,000
$523,700
$74,416
$400,004
$37,500
Cost of goods sold
$724,353
$731,195
$0
$0
$0
Gross margin
-35%
-40%
100%
100%
100%
Net income
-$269,672
-$134,068
-$96,310
$81,336
-$194,403
Taxes paid
$0
$0
$26
$6,320
$6,925
Balance sheet
Cash
$203,237
$85,011
$5,436
$88,297
$33,387
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$221,539
$208,505
$104,168
$229,181
$207,870
Short-term debt
$0
$86,000
$109,021
$147,661
$168,436
Long-term debt
$117,200
$160,300
$255,356
$260,392
$253,313
Total liabilities
$117,200
$246,300
$364,377
$408,054
$421,750
Other
Headcount
—
5
—
2
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$11.1M
post-money
MicroMGx Inc Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $124.5K / $1.1MPost-money $11.1M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 11 filings on EDGARSource: ManualCIK 0001941410Share price $2.37
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.